We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Aspiration Cytology Is a Resource for Molecular Profiling

By LabMedica International staff writers
Posted on 23 Nov 2010
Archived and stained fine needle aspirate smears can be used for clinical molecular diagnosis and profiling. More...


DNA can be extracted from aspirate smears stained with Papanicolau (Pap) and Diff-Quick (DQ) stains that were prepared by technicians in a single laboratory according to standard procedure, mounted with a glass coverslips, and stored at room temperature under typical pathology archive conditions.

In a study performed at the National Cancer Institute, (Bethesda, MD, USA), 57 fine-needle aspiration cytopathology (FNAC) samples were examined for aberration detection on high-resolution comparative genomic hybridization array, DNA methylation, and single nucleotide polymorphism genotyping platforms. The samples were from patients with suspected small cell lung cancer (SCLC), metastatic lymph node cancer, and/or primary lymphoma.

Cellular material is collected by scraping the entire slide with a razor blade; this is facilitated by wetting the slide with a small amount of about 20 µL of lysis buffer, which helps the material form a clump during scraping. The average DNA yield per slide in this study was 7.4 µg (range: 0.1 µg to 27.9 µg). Unequivocal genomic structural aberrations were identified in 44 of 46 malignant smears. Even the degraded archival Pap smear DNA showed similar structural aberrations matched to DQ samples on Agilent array comparative genomic hybridization (Agilent; Santa Clara, CA, USA) and Infinium genotyping (Illumina; San Diego, CA, USA), although with greater background noise.

The authors of the study concluded, "Cytopathology specimens are an excellent potential source of patient materials for clinical molecular profiling, including retrospective genomic analyses and prospective sample collection for individualized therapy or eligibility review for clinical trial enrollment. FNAC samples up to 16 years old yielded copious quantities of genomic DNA suitable for high-resolution genomic and epigenomic profiling". The study was published in November 2010, in the Journal of Molecular Diagnostics.

Related Links:

National Cancer Institute
Agilent
Illumina



New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
Laboratory Software
ArtelWare
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.